“Real World Data Survival Outcomes of First Line Immunotherapy With Pembrolizumab in High Expressers With Stage IV Non-Small Cell Lung Cancer”. Radiology and Oncology 60, no. 3 (September 2, 2026): 450–458. Accessed September 22, 2026. https://radioloncol.com/index.php/ro/article/view/4876.